Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Louis Kwong

Adult Reconstructive Orthopaedic Surgery Torrance, CA Medical Doctor

NPI 1750450276 CMS profile 215162

1000 W Carson St Rm 4L1, Torrance, CA 90502

Open in the dashboard

General payments

$618,960

426 records reported · program years 2019–2025

Research payments

$9,986

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$339,144 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Louis Kwong of Torrance, CA is reported in the CMS Open Payments database as having received $618,960 across 426 general payments and $9,986 in research payments paid to them. Separately, studies naming them as principal investigator received $339,144 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $104,762 5
2024 General $39,404 4
2023 General $121,266 62
2022 General $96,635 66
2021 General $107,948 90
2021 Research $9,986 1
2020 General $52,700 77
2019 General $96,245 122

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Louis Kwong
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Louis Kwong were reported at $104,762. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Louis Kwong Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $96,245 $1,416 $292–$9,336 $163
2020 $52,700 $647 $141–$6,474 $114
2021 $107,948 $1,073 $211–$6,497 $132
2022 $96,635 $1,217 $236–$6,299 $149
2023 $121,266 $1,082 $246–$6,818 $160
2024 $39,404 $1,575 $323–$8,944 $164
2025 $104,762 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $589,304 333 payments
  2. ConvaTec Inc. $16,218 20 payments
  3. Heron Therapeutics, Inc. $5,647 18 payments
  4. Regeneron Pharmaceuticals, Inc. $3,200 1 payment
  5. Musculoskeletal Transplant Foundation Inc. $1,787 14 payments
  6. Janssen Research & Development, LLC $983 6 payments
  7. Dne LLC $622 2 payments
  8. Molnlycke Health Care US, LLC $209 3 payments
  9. Stryker Corporation $154 1 payment
  10. DePuy Synthes Sales Inc. $122 1 payment
  11. Other $712 27 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $342,970 17 payments
  2. Consulting Fee $251,950 166 payments
  3. Travel and Lodging $17,651 103 payments
  4. Food and Beverage $6,388 140 payments
Products named General payments · program years 2019–2025
  1. Persona Knees $301,465 54 payments
  2. Persona Revision $97,696 45 payments
  3. Persona Knees $83,223 70 payments
  4. LCCK NexGen $26,212 27 payments
  5. Trabecular Metal (TM) $25,375 17 payments
  6. Acetabular $25,375 17 payments
  7. NexGen $20,412 9 payments
  8. RHK $17,162 7 payments
  9. AQUACEL AG $12,391 14 payments
  10. Fuzion $8,625 3 payments
  11. Other $72,489 185 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $9,986 1 payment

Records

427 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record